This content is exclusively provided by FAO / FAOLEX

National Medicines Regulatory Authority Act, No. 5 of 2015.

Country
Type of law
Legislation
Source

Abstract
This Act establishes the National Medicines Regulatory Authority (Authority) and provides for its functions and powers in respect of medicines and medical devices. Chapter I states the objects of the Authority and contains the composition of the Authority. It lays down the powers and functions of the Authority. Chapter II establishes the National Advisory Committee and its divisions and provides for the National Medicines Quality Assurance Laboratory. Chapter III lays down the functions of the Medicines Regulatory Division of the Authority and provides for the registration and licensing of medicines. Chapter IV controls and regulates all aspects of medical devices. Chapter VI contains provisions in respect of sale, manufacturing, import and pricing of medicines and medical devices. Chapter VII regulates pharmacies and contains powers of authorised officers.
Long title of text
An act to provide for the establishment of a regulatory authority to be known as the National Medicines Regulatory Authority which shall be responsible for the regulation and control of, registration, licensing, manufacture, importation and all other aspects pertaining to medicines, medical devices, borderline products and for the conducting of clinical trials in a manner compatible with the national medicines policy; to provide for the establishment of divisions of the National Medicines Regulatory Authority including the medicines regulatory division, medical devices regulatory division, borderline products regulatory division and clinical trials regulatory division; to establish a national advisory body; to repeal the Cosmetics, Devices and Drugs Act, No. 27 of 1980; and for matters connected therewith or incidental thereto.
Date of text
Notes
This Act repeals the Cosmetics, Devices and Drugs Act, No. 27 of 1980.
Repealed
No
Source language

English

Legislation Amendment
No